NCT01497873 2018-12-27A Randomized Study to Compare the Efficacy and Safety of Belotecan and Topotecan as Monotherapy for Sensitive-Relapsed Small Cell Lung CancerChong Kun Dang PharmaceuticalPhase 2 Completed164 enrolled